Component
Rat carbohydrate-responsive element-binding protein / ChREBP
Species, exposure, manipulation and evidence limits are specified on each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
PF-06835919 reduced fructose-associated nuclear ChREBP localization in primary rat hepatocytes.
Experimental context and source evidence
- dose
- 10 mM fructose with or without 30 micromolar PF-06835919
- duration
- Overnight
- evidence_access
- Primary full-text methods/results and metadata inspected.
- evidence_scope
- literature_reviewed; source-specific curation
- experimental_model
- Primary rat hepatocytes
- exposure_scope
- Isolated fructose / investigational drug
- limitations
- Cell-model transcriptional effect; not established human lipid or disease prevention.
- nutrient_topic
- HFCS chapter: actual formulation studies, component biochemistry and interventions are explicitly distinguished. · High-Fructose Corn Syrup / HFCS
- organism
- Primary rat hepatocytes
- plain_language
- PF-06835919 reduced fructose-associated nuclear ChREBP localization in primary rat hepatocytes.
- primary_references
- Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction. (2021). https://pubmed.ncbi.nlm.nih.gov/33667726/ DOI: 10.1016/j.molmet.2021.101196
- route
- In vitro exposure
- tissue
- ChREBP nuclear localization
High-Fructose Corn Syrup: mechanism of action and metabolic impact (2026-09-20) · lines 581–591
Original AI-assisted curation of twenty primary studies and official FDA composition information, with one reused canonical glucose-transport claim. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · Primary rat hepatocytes · source_derived_draft · unverified_draft
## hfcs-pf-chrebp PF-06835919 reduced fructose-associated nuclear ChREBP localization in primary rat hepatocytes. Model/species: Primary rat hepatocytes Tissue: ChREBP nuclear localization Exposure: 10 mM fructose with or without 30 micromolar PF-06835919 Route: In vitro exposure Duration: Overnight Exposure scope: Isolated fructose / investigational drug Limits: Cell-model transcriptional effect; not established human lipid or disease prevention. Reference: Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction. (2021). https://pubmed.ncbi.nlm.nih.gov/33667726/ DOI: 10.1016/j.molmet.2021.101196 Access: Primary full-text methods/results and metadata inspected.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.